Cash & equivalents increased 1426.1%
Cash & equivalents changed +1426.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +1426.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross margin changed +3692 basis points from the comparable as-filed period.
Gross profit changed +1391.0% from the comparable as-filed period.
Inventory changed +20.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed +258.8% from the comparable as-filed period.
Operating income changed +254.5% from the comparable as-filed period.
Operating margin changed +5943 basis points from the comparable as-filed period.
Research & development changed +44.6% from the comparable as-filed period.
Revenue changed +164.8% from the comparable as-filed period.
Selling, general & administrative changed +29.0% from the comparable as-filed period.
Debt changed +13.0% from the comparable as-filed period. The change ranks at the 0th percentile of 5 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.